The Mid-South clinical Data Research Network.

The Mid-South Clinical Data Research Network (CDRN) encompasses three large health systems: (1) Vanderbilt Health System (VU) with electronic medical ...
2MB Sizes 4 Downloads 4 Views

Recommend Documents


The louisiana clinical data research network: leveraging regional and national resources to improve clinical research efficiency.
Mapping of the human genome and technological advancements allowing storage and rapid retrieval of healthcare data have heralded a new phase in clinical medicine and have served as a catalyst for the advent of personalized medicine. The use of health

Changing the research landscape: the New York City Clinical Data Research Network.
The New York City Clinical Data Research Network (NYC-CDRN), funded by the Patient-Centered Outcomes Research Institute (PCORI), brings together 22 organizations including seven independent health systems to enable patient-centered clinical research,

Louisiana Clinical Data Research Network: establishing an infrastructure for efficient conduct of clinical research.
The state of Louisiana, like the nation as a whole, is facing the salient challenge of improving population health and efficiency of healthcare delivery. Research to inform innovations in healthcare will best enhance this effort if it is timely, effi

Clinical research: a globalized network.
Clinical research has become increasingly globalized, but the extent of globalization has not been assessed. To describe the globalization of clinical research, we used all (n = 13,208) multinational trials registered at ClinicalTrials.gov to analyze

The Function Biomedical Informatics Research Network Data Repository.
The Function Biomedical Informatics Research Network (FBIRN) developed methods and tools for conducting multi-scanner functional magnetic resonance imaging (fMRI) studies. Method and tool development were based on two major goals: 1) to assess the ma

A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens.
Advances in cancer research and personalized medicine will require significant new bridging infrastructures, including more robust biorepositories that link human tissue to clinical phenotypes and outcomes. In order to meet that challenge, four cance

Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely "orphan drugs", have recently drawn the attention of researchers and pharmaceutical companies. To ens